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Remodeling is defined as modeling again or differently, 
as reconstructing. Remodeling is a critical aspect of wound 
repair in all organs; it represents a dynamic process that 
associates the production and degradation of matrix in 
reaction to inflammation. This leads to normal reconstruction 
or a pathologic process. Aim and Methods: To compare 
data in the current literature on upper and lower airways. 
Results: Asthma is a chronic inflammatory disease associated 
with abnormal airways remodeling. In allergic rhinitis, 
another chronic inflammatory disease, remodeling is still 
poorly understood. Even though inflammation is similar in 
allergic rhinitis and asthma, the pathologic extent of nasal 
remodeling, as well as its clinical consequences, might be 
different from those in bronchi. Conclusion: Remodeling 
occurs less in upper airways compared to lower airways; it 
is apparent, however, that the structure of the rhinitic nose 
is not normal.
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INTRODUCTION
Remodeling may be defined as modeling again or 
rebuilding. It is a critical aspect of injury repair processes 
in every organ of the body; either normal tissue is rebuilt 
or pathological tissue is formed.1 The main histological 
features of chronic inflammation and remodeling are: 
macrophage and lymphocyte infiltration, fibroblast pro-
liferation (which may become myofibroblasts), angioge-
nesis, increased connective tissue (fibrosis) and tissue 
destruction.2
Allergic rhinitis is inflammation of upper airways; 
inflammation alone, however, does not explain the chro-
nic nature of this condition. The role of the bronchial 
epithelium as a key regulator of airway inflammation and 
remodeling responses may be demonstrated in asthma. 
Many studies are trying to demonstrate the same finding 
in upper airways.3
Although asthma may be seen as a reversible airflow 
obstruction condition, many adult and child asthmatics 
show evidence of residual airway obstruction, which is 
detected even in asymptomatic patients. This irreversible 
component of airway obstruction results from structural 
bronchial alterations that change the shape of airways and 
result in variable degrees of loss of function.2,4
The purpose of this paper was to compare existing 
data in the literature on upper and lower airway remode-
ling, since there are few published papers in our setting 
on this theme.
REVIEW OF THE LITERATURE
 
1. Lower airways
Airway remodeling is a dynamic process in which 
extracellular matrix is deposited and degraded in response 
to trauma, resulting in reconstruction of damaged tissue 
that is very important for healing.2 Remodeling in asthma 
has been studied in detail; it includes changes in airway 
epithelium, lamina propria and submucosa, in which the 
walls become thickened. Inflammation in asthma may be 
mediated by Th2 lymphocytes, which secrete cytokines 
that orchestrate cell inflammation and bronchial hyper-
responsiveness.5
 
1.1 Histopathological features
 
Thickening of the reticular basal membrane
The epithelial basement membrane in human ai-
rways is composed of two layers, the basal lamina, which 
is considered the true basement membrane and which 
is not thickened in asthmatics, and the reticular lamina, 
which is formed by types I, III and V, and fibronectin, and 
is thickened is asthma.6 This is a common, consistent and 
early feature in the pathology of asthma.7 There is plexi-
form deposition of immunoglobulins, collagen I and III, 
tenascin and fibronectin; there is no evidence of laminin 
deposition.2,8 These proteins are produced by activated 
myofibroblasts, which leads to subepithelial fibrosis.2,9 
Thickening of the basement membrane was not related 
to the severity, duration or etiology of asthma in some 
studies;10 others, however, have reported a correlation 
between these findings and disease severity.11
 
Interstitial matrix
The presence of an abnormal superficial network 
of elastic fibers has been reported in asthmatics, which 
suggests an elastolytic process. Deeper elastic fibers are 
also altered in many asthmatics.2,12
The submucosa of asthmatics may show collagen 
fiber hyperplasia, and fibronectin, laminin and tenascin 
deposits.2,13
 
Blood vessels
Increased vasculature, vasodilatation and micro-
vascular extravasation are features of airway wall re-
modeling. Patients with fatal asthma have an increased 
number of blood vessels; in these cases, however, the 
extension of neovascularization and angiogenesis remain 
uncertain.14,15
 
Smooth muscle
Studies on cadavers have shown bronchial smooth 
muscle hypertrophy and hyperplasia in asthmatics.16 Ani-
mal experiments have shown that prolonged exposure 
to allergens may increase the thickness of airway smooth 
muscles.17
 
Glands
Remodeling in asthma may include goblet cell 
hyperplasia, mucous gland hypertrophy and increased 
mucus production.18,19
 
1.2 Mediators
CD4+ lymphocytes have an important role in re-
modeling responses; they generate Th2 cytokines, such as 
interleukins (IL) 5 and 13, and promote fibrosis.6,20,21 Eosi-
nophils are highly active in asthma remodeling, particularly 
through the transforming growth factor β1 (TGF-β1), one 
of its main mediators.20
Other mediators with elevated levels are: the epider-
mal growth factor (EGF), the fibroblast growth factor, the 
vascular endothelial growth factor (VEGF), IL-11, elastase, 
endothelin, matrix metalloproteinases (MMPs) 2 and 9, and 
the tissue inhibitor of metalloproteinase 1 (TIMP-1).2,22,23
Mast cells are also important in remodeling; they 
activate mesenchymal cells by mediators such as tryptase, 
a potent stimulator of fibroblast and smooth muscle cell 
proliferation.24,25 Another mediator released by mast cells 
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is the type 1 plasminogen activation inhibitor, which is 
also associated with remodeling.26
The role of certain genes is being debated, such as 
the anchored protein gene containing a disintegrin and a 
metalloproteinase on domain 33 gene (ADAM 33), which 
may affect tissue repair processes.23,27
 
1.3 Response to therapy
There has been much about the possibility of 
preventing remodeling in asthma by early treatment with 
various drugs. Inhaled corticosteroids are the mainstay of 
asthma therapy. It is thought that the anti-inflammatory 
effect of these drugs may - at least partially - reduce the 
amount of cytokines and mediators that are responsible for 
chronic inflammation and remodeling in this condition.28,29 
Inhaled corticosteroids are able to decrease subepithelial 
fibrosis, basement membrane thickness and bronchial 
hyperreactivity. Airway vascularization is also decreased 
by inhaled corticosteroid therapy, although VEGF levels 
remain unchanged.30,31 Other drugs such as leukotriene 
inhibitors, ketotifen, sodium cromoglycate and teophilin 
are anti-inflammatory drugs, but less effective than corti-
costeroids. The role of these drugs in remodeling remains 
uncertain.28-30
Immune stimulators, such as anti-IL-5 and the CpG-
containing immune stimulatory sequence (CpG DNA), 
are a future perspective. These drugs decrease TGF-β1 
expression, and therefore remodeling.20
 
2. Upper airways
 
2.1 Allergic rhinitis
Although inflammation is similar in allergic rhinitis 
and asthma, remodeling is less pronounced in rhinitis. The 
reasons for this are not clear, and two hypotheses have 
been raised: cytokines may be produced specifically by 
bronchial smooth muscle cells, and these conditions may 
have a different embryonic origin (the nose is ectodermal 
and bronchi are endodermal), where persistent (asthma) 
or re-expressed (rhinitis) embryologic differentiating genes 
lead to different remodeling patterns.23
 
2.1.1 Histopathological features
 
Epithelium
Few studies have investigated the nasal epithelium 
in allergic rhinitis patients; those that have show conflicting 
results. These patients have signs of remodeling not only 
in the nasal mucosa but also in the bronchial epithelium, 
regardless of the presence or absence of asthma. Brauns-
tahl et al. demonstrated that there were more eosinophils 
in the nasal and bronchial mucosa, a thickened basement 
membrane, and epithelial desquamation in the bronchial 
mucosa of allergic rhinitis patients with no asthma. There 
was, however, no structural change in the nasal mucosa.32 
The definition of abnormality in this study was the presen-
ce of clear rupture, similar to asthma. In the latter, this is 
a significant finding, probably related to dynamic forces 
on the epithelium during bronchoconstriction, which is 
absent in the nose.33 Although there is no clear epithelial 
rupture in allergic rhinitis as there is in asthma, there may 
be subtle changes detected only by electron microscopy, 
such as cytoplasmatic vacuoles and increased intercellu-
lar space.34 Ciliated cell dysplasia and metaplasia may be 
found in allergic rhinitis.35
 
Reticular basal membrane
Similar to asthma, the reticular portion of the base-
ment membrane is thickened in the nasal epithelium of 
allergic rhinitis patients, as has been shown in a number 
of papers.
Chakir et al. biopsied the bronchi of non-asthmatic 
allergic rhinitis patients and found that type I and III colla-
gen and fibronectin were elevated in the reticular portion 
of the basement membrane; this was associated with a 
network of myofibroblasts along the epithelium, similar 
to findings in asthma, albeit less intense. These authors 
concluded that subepithelial fibrosis in rhinitis results from 
the deposition of type I and III collagen and fibronectin, 
which are produced by bronchial myofibroblasts.36
Montero et al. biopsied the lower turbinate in 26 
untreated allergic rhinitis patients and found that the ba-
sement membrane was thickened in 92.3% of cases, that 
there was subepithelial fibrosis in 92.4% of cases, neutro-
phils, eosinophils and lymphocytes were found in 100% 
of cases, edema in 46.2% of cases and vascular dilatation 
was present in 11.1% of cases, suggesting that remodeling 
was taking place in allergic rhinitis.37 Sanai et al. compa-
red the mucosa of the lower turbinate in allergic rhinitis 
patients with non-allergic controls and found that type I 
and III collagen was much more significantly deposited 
in the reticular portion of the basement membrane with 
resulting thickening in allergic rhinitis. The total amount of 
collagen, however, was similar in both groups; the authors 
suggested that nasal mucosa remodeling occurs immedia-
tely below the epithelium in the basement membrane, by 
collagen deposition.38 Agha-Mir-Salim et al. studied the 
basement membrane of the lower turbinate and found that 
thickening of this layer is common, as it helps stabilize 
the epithelium mechanically. Collage deposits, therefore, 
would act as a mechanical control mechanism to avoid 
excessive expansion of the nasal mucosa, thus keeping 
the nasal cavity patent.39 Sanai et al. have suggested that 
allergic inflammation accelerates the physiological mecha-
nism of collagen deposition in the basement membrane 
of the lower turbinate, resulting in fibrosis.38
 
Glands
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The nasal mucosa contains goblet cells, which are 
unicellular mucus-secreting glands located above the epi-
thelial basement membrane; there are also deep glands 
in the lamina propria. There is no consensus about whe-
ther goblet cells are more numerous in rhinitis; there are, 
however, structural changes such as distended acini with 
secretion, and acini and duct degeneration and obstruc-
tion. Compression, atrophy and dilatation may be found 
in deep mucosal glands.33
 
Blood vessels
Angiogenesis has not been clearly established in 
allergic rhinitis. A study measuring vessel surface and volu-
me density has shown no difference between normal and 
rhinitis patients.40 On the other hand, angiogenic factors 
such as the platelet-derived endothelial cell growth factor 
and the VEGF have been found at elevated levels in rhi-
nitis patients.23,33 Other indicators of vascular change may 
be seen, such as arteriolar wall thinning and destruction, 
globulin and complement deposits on vascular walls and 
vasodilatation.33
 
2.1.2 Mediators
Remodeling, collagen deposits and other extra-
cellular matrix product deposition may be at least partially 
attributed to an increased fibroblast number and activity. 
Ongoing research is searching for mediators and cytoki-
nes such as the TGF-β1 and the granulocyte macrophage 
colony growth factor (GM-CSF), which may be released 
by local inflammatory cells to activate those fibroblasts.41,42 
Nitric oxide (NO) is a key mediator for the endothelium-
derived relaxing factor (EDRF) that is responsible for rela-
xing vascular smooth muscle.43 NO is elevated in asthmatic 
and allergic rhinitis patients, and may be used in future as 
a marker for airway inflammation. There is also interest in 
NO as an inflammation and remodeling agent. Tewfik et 
al. demonstrated that NO stimulates collagen expression 
by fibroblasts derived from nasal polyps in patients tested 
positive for allergy.42
Various other cytokines have been investigated for 
their possible role in airway remodeling. Oncostatin M (IL-6 
family), for instance, is expressed in the nasal mucosa and 
has been found to be elevated in allergic rhinitis patients.44 
The heme oxygenase enzyme, an antioxydating agent 
that catabolizes heme into carbon monoxide (CO) and 
biliverdin, has an important cell-protecting action against 
oxidative injury. Elhini et al. found that heme oxygenase 
1 (HO-1) was elevated in the tissues of allergic rhinitis 
patients, and concluded that improved understanding of 
HO-1 expression may improve the management of rhinitis 
in future.45
MMPs are proteolytic enzymes involved in extra-
cellular matrix turnover.46 Studies of MMP-9 have not 
demonstrated any elevation in perennial allergic rhinitis;47 
however, 3 to 10 hours after exposure to nasal allergens, 
the eosinophilic cationic protein (ECP) and MMP-9 are 
elevated.48 Significant amounts of TIMP-1 and TIMP-2 
mRNA may be found in the nasal mucosa of perennial 
allergic rhinitis patients.47
Table 1 contains a summary of upper and lower 
airway remodeling.
 
2.2 Chronic rhinosinusitis
Remodeling of the mucosa is also found in chronic 
sinus disease, similar to asthma and allergic rhinitis. Po-
nikau et al. encountered increased basement membrane 
thickening, epithelial injury and heterogeneous eosinophi-
lic inflammation in the sinus mucosa of allergic and non-
allergic chronic rhinosinusitis (CRS) patients, suggesting 
that a similar process occurs in asthma and CRS.49 Sobol et 
al. compared the sinus mucosa of CRS adults and children 
with controls and found an increased number of eosino-
phils and subepithelial collagen deposits in both CRS adults 
and children (to a lesser degree). These results suggest 
that remodeling begins early and, if not interrupted, may 
cause irreversible changes in the sinus mucosa.50
 
2.3 Response to therapy
Some allergic rhinitis and CRS patients respond very 
well to medical treatment, especially therapy with nasal 
Table 1. Comparison of remodeling between upper and lower airways.
Lower airways    Upper airways
Epithelium    Evident structural changes with rupture franca    Subtle structural changes
Reticular basement 
membrane
Mainly thickening and collagen I and III deposits Similar to lower airways
Blood vessels    
Increased vascularization, vasodilatation and microvas-
cular extravasation
Angiogenesis not yet demonstrated conclusively. Pre-
sence of mild vascular changes
Glands    
Goblet cell and mucous gland hyperplasia and increa-
sed mucus production    
Distended, degenerated and obstructed acini and 
ducts
Response to therapy    
Inhaled corticosteroids decrease subepithelial fibrosis, 
there is decreased basement membrane thickening 
and bronchial hyperreactivity    
Absence of conclusive studies
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corticosteroids. Other, however, do not benefit from such 
therapy, and become candidates for surgery. The issue is 
to find the difference between both groups and by how 
much remodeling is part of this difference.
FINAL COMMENTS
Tissue remodeling in response to chronic inflamma-
tion has been own in all body systems. It has been widely 
demonstrated in lower airways, especially in asthmatics. 
Upper airway remodeling is being investigated; there is 
strong evidence suggesting that it occurs in allergic rhinitis 
and CRS, particularly by eosinophilic inflammation. Upper 
airway remodeling is less intense compared to lower ai-
rway remodeling; it is, however, apparent that the nasal 
mucosa in rhinitis patients is not normal. Further studies 
are needed, since many steps need to be clarified before 
the whole process is understood.
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